BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009;24:652-657. [PMID: 19175831 DOI: 10.1111/j.1440-1746.2008.05666.x] [Cited by in Crossref: 336] [Cited by in F6Publishing: 328] [Article Influence: 24.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun D, Yu F, Ma Y, Zhao R, Chen X, Zhu J, Zhang CY, Chen J, Zhang J. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol Chem. 2013;288:9508-9518. [PMID: 23322774 DOI: 10.1074/jbc.m112.367763] [Cited by in Crossref: 112] [Cited by in F6Publishing: 90] [Article Influence: 12.4] [Reference Citation Analysis]
2 Li N, Liu Y, Miao Y, Zhao L, Zhou H, Jia L. MicroRNA-106b targets FUT6 to promote cell migration, invasion, and proliferation in human breast cancer. IUBMB Life 2016;68:764-75. [PMID: 27519168 DOI: 10.1002/iub.1541] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
3 Aprelikova O, Yu X, Palla J, Wei BR, John S, Yi M, Stephens R, Simpson RM, Risinger JI, Jazaeri A, Niederhuber J. The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle 2010;9:4387-98. [PMID: 20980827 DOI: 10.4161/cc.9.21.13674] [Cited by in Crossref: 113] [Cited by in F6Publishing: 141] [Article Influence: 9.4] [Reference Citation Analysis]
4 Su Y, Ni Z, Wang G, Cui J, Wei C, Wang J, Yang Q, Xu Y, Li F. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p. Int Immunopharmacol. 2012;13:468-475. [PMID: 22683180 DOI: 10.1016/j.intimp.2012.05.016] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
5 Cheng J, Deng H, Xiao B, Zhou H, Zhou F, Shen Z, Guo J. piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Lett. 2012;315:12-17. [PMID: 22047710 DOI: 10.1016/j.canlet.2011.10.004] [Cited by in Crossref: 156] [Cited by in F6Publishing: 145] [Article Influence: 14.2] [Reference Citation Analysis]
6 Wang H, Ruan H, He X, Ma Y, Jiang X, Xia Y, Ye Z, Tao H. MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. European Journal of Cancer 2010;46:2295-303. [DOI: 10.1016/j.ejca.2010.05.012] [Cited by in Crossref: 180] [Cited by in F6Publishing: 163] [Article Influence: 15.0] [Reference Citation Analysis]
7 Tong F, Cao P, Yin Y, Xia S, Lai R, Liu S. MicroRNAs in gastric cancer: from benchtop to bedside. Dig Dis Sci. 2014;59:24-30. [PMID: 24114043 DOI: 10.1007/s10620-013-2887-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
8 Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z, Chun-Sheng K. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 2010;10:367. [PMID: 20618998 DOI: 10.1186/1471-2407-10-367] [Cited by in Crossref: 262] [Cited by in F6Publishing: 246] [Article Influence: 21.8] [Reference Citation Analysis]
9 Khalili N, Nouri-Vaskeh M, Hasanpour Segherlou Z, Baghbanzadeh A, Halimi M, Rezaee H, Baradaran B. Diagnostic, prognostic, and therapeutic significance of miR-139-5p in cancers. Life Sci 2020;256:117865. [PMID: 32502540 DOI: 10.1016/j.lfs.2020.117865] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
10 Song M, Yin Y, Zhang J, Zhang B, Bian Z, Quan C, Zhou L, Hu Y, Wang Q, Ni S, Fei B, Wang W, Du X, Hua D, Huang Z. MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. Protein Cell 2014;5:851-61. [PMID: 25149074 DOI: 10.1007/s13238-014-0093-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
11 Shen J, Stass SA, Jiang F. MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett. 2013;329:125-136. [PMID: 23196059 DOI: 10.1016/j.canlet.2012.11.001] [Cited by in Crossref: 153] [Cited by in F6Publishing: 153] [Article Influence: 15.3] [Reference Citation Analysis]
12 Shao Y, Li J, Lu R, Li T, Yang Y, Xiao B, Guo J. Global circular RNA expression profile of human gastric cancer and its clinical significance. Cancer Med. 2017;6:1173-1180. [PMID: 28544609 DOI: 10.1002/cam4.1055] [Cited by in Crossref: 125] [Cited by in F6Publishing: 146] [Article Influence: 25.0] [Reference Citation Analysis]
13 Wu W, Takanashi M, Borjigin N, Ohno SI, Fujita K, Hoshino S, Osaka Y, Tsuchida A, Kuroda M. MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis. Br J Cancer. 2013;108:653-661. [PMID: 23322197 DOI: 10.1038/bjc.2012.587] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 7.8] [Reference Citation Analysis]
14 Kim BH, Hong SW, Kim A, Choi SH, Yoon SO. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol. 2013;107:505-510. [PMID: 22996433 DOI: 10.1002/jso.23271] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 7.7] [Reference Citation Analysis]
15 Hua S, Lei L, Deng L, Weng X, Liu C, Qi X, Wang S, Zhang D, Zou X, Cao C, Liu L, Wu D. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Oncogene. 2018;37:1624-1636. [PMID: 29335523 DOI: 10.1038/s41388-017-0057-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 15.8] [Reference Citation Analysis]
16 Zhuang M, Gao W, Xu J, Wang P, Shu Y. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun. 2014;448:315-322. [PMID: 24388988 DOI: 10.1016/j.bbrc.2013.12.126] [Cited by in Crossref: 124] [Cited by in F6Publishing: 136] [Article Influence: 15.5] [Reference Citation Analysis]
17 Xu XL, Jiang YH, Feng JG, Su D, Chen PC, Mao WM. MicroRNA-17, microRNA-18a, and microRNA-19a are prognostic indicators in esophageal squamous cell carcinoma. Ann Thorac Surg 2014;97:1037-45. [PMID: 24360091 DOI: 10.1016/j.athoracsur.2013.10.042] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
18 Huang S, Wang J, Li J, Luo Q, Zhao M, Zheng L, Dong X, Chen C, Che Y, Liu P. Serum microRNA expression profile as a diagnostic panel for gastric cancer. Jpn J Clin Oncol. 2016;46:811-818. [PMID: 27380811 DOI: 10.1093/jjco/hyw085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
19 Leja M, Wex T, Malfertheiner P. Markers for gastric cancer premalignant lesions: where do we go? Dig Dis. 2012;30:268-276. [PMID: 22722551 DOI: 10.1159/000336990] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
20 Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z, Cheng J, Xiao BX. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl). 2010;88:709-717. [PMID: 20349219 DOI: 10.1007/s00109-010-0617-2]] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Guo L, Bai H, Zou D, Hong T, Liu J, Huang J, He P, Zhou Q, He J. The role of microRNA-133b and its target gene FSCN1 in gastric cancer. J Exp Clin Cancer Res. 2014;33:99. [PMID: 25433493 DOI: 10.1186/s13046-014-0099-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
22 Ma YY, Tao HQ. Microribonucleic acids and gastric cancer. Cancer Sci 2012;103:620-5. [PMID: 22168593 DOI: 10.1111/j.1349-7006.2011.02185.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
23 Grady WM, Tewari M. The next thing in prognostic molecular markers: microRNA signatures of cancer. Gut 2010;59:706-8. [PMID: 20551450 DOI: 10.1136/gut.2009.200022] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
24 Guo SL, Peng Z, Yang X, Fan KJ, Ye H, Li ZH, Wang Y, Xu XL, Li J, Wang YL, Teng Y, Yang X. miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells. Int J Biol Sci 2011;7:567-74. [PMID: 21552422 DOI: 10.7150/ijbs.7.567] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 7.0] [Reference Citation Analysis]
25 Vriens MR, Weng J, Suh I, Huynh N, Guerrero MA, Shen WT, Duh QY, Clark OH, Kebebew E. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer 2012;118:3426-32. [PMID: 22006248 DOI: 10.1002/cncr.26587] [Cited by in Crossref: 90] [Cited by in F6Publishing: 78] [Article Influence: 8.2] [Reference Citation Analysis]
26 Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM, Li Y, Nelson RA, Mu B, Onami SH. Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One. 2012;7:e35661. [PMID: 22623952 DOI: 10.1371/journal.pone.0035661] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 12.3] [Reference Citation Analysis]
27 Mazzoccoli G, Colangelo T, Panza A, Rubino R, Tiberio C, Palumbo O, Carella M, Trombetta D, Gentile A, Tavano F, Valvano MR, Storlazzi CT, Macchia G, De Cata A, Bisceglia G, Capocefalo D, Colantuoni V, Sabatino L, Piepoli A, Mazza T. Analysis of clock gene-miRNA correlation networks reveals candidate drivers in colorectal cancer. Oncotarget 2016;7:45444-61. [PMID: 27323779 DOI: 10.18632/oncotarget.9989] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
28 Chen P, Yao GD. The role of cullin proteins in gastric cancer. Tumour Biol 2016;37:29-37. [PMID: 26472722 DOI: 10.1007/s13277-015-4154-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
29 Saran U, Chandrasekaran B, Kolluru V, Tyagi A, Nguyen KD, Valadon CL, Shaheen SP, Kong M, Poddar T, Ankem MK, Damodaran C. Diagnostic molecular markers predicting aggressive potential in low-grade prostate cancer. Transl Res 2021;231:92-101. [PMID: 33279680 DOI: 10.1016/j.trsl.2020.11.014] [Reference Citation Analysis]
30 Zhao H, Li M, Li L, Yang X, Lan G, Zhang Y. MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis. PLoS One 2013;8:e83571. [PMID: 24391788 DOI: 10.1371/journal.pone.0083571] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 7.2] [Reference Citation Analysis]
31 Nam RK, Benatar T, Wallis CJ, Amemiya Y, Yang W, Garbens A, Naeim M, Sherman C, Sugar L, Seth A. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence. Prostate 2016;76:869-84. [PMID: 26990571 DOI: 10.1002/pros.23177] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 6.2] [Reference Citation Analysis]
32 Ma Y, Dong C, Chen X, Zhu R, Wang J. Silencing of miR-20b-5p Exerts Inhibitory Effect on Diabetic Retinopathy via Inactivation of THBS1 Gene Induced VEGF/Akt/PI3K Pathway. Diabetes Metab Syndr Obes 2021;14:1183-93. [PMID: 33758526 DOI: 10.2147/DMSO.S299143] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Schaefer JS, Montufar-Solis D, Vigneswaran N, Klein JR. Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon. J Immunol 2011;187:5834-41. [PMID: 22043014 DOI: 10.4049/jimmunol.1100922] [Cited by in Crossref: 79] [Cited by in F6Publishing: 81] [Article Influence: 7.2] [Reference Citation Analysis]
34 Tömböl Z, Eder K, Kovács A, Szabó PM, Kulka J, Likó I, Zalatnai A, Rácz G, Tóth M, Patócs A, Falus A, Rácz K, Igaz P. MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas. Mod Pathol 2010;23:1583-95. [PMID: 20818339 DOI: 10.1038/modpathol.2010.164] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
35 Wang C, Ji B, Cheng B, Chen J, Bai B. Neuroprotection of microRNA in neurological disorders (Review). Biomed Rep. 2014;2:611-619. [PMID: 25053999 DOI: 10.3892/br.2014.297] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
36 Shrestha S, Hsu SD, Huang WY, Huang HY, Chen W, Weng SL, Huang HD. A systematic review of microRNA expression profiling studies in human gastric cancer. Cancer Med. 2014;3:878-888. [PMID: 24902858 DOI: 10.1002/cam4.246] [Cited by in Crossref: 90] [Cited by in F6Publishing: 99] [Article Influence: 11.3] [Reference Citation Analysis]
37 Lin N, Zhou Y, Lian X, Tu Y. MicroRNA-31 functions as an oncogenic microRNA in cutaneous squamous cell carcinoma cells by targeting RhoTBT1. Oncol Lett 2017;13:1078-82. [PMID: 28454216 DOI: 10.3892/ol.2017.5554] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
38 Burkhart DL, Ngai LK, Roake CM, Viatour P, Thangavel C, Ho VM, Knudsen ES, Sage J. Regulation of RB transcription in vivo by RB family members. Mol Cell Biol 2010;30:1729-45. [PMID: 20100864 DOI: 10.1128/MCB.00952-09] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
39 Liu L, Chen Q, Lai R, Wu X, Wu X, Liu F, Xu G, Ji Y. Elevated expression of mature miR-21 and miR-155 in cancerous gastric tissues from Chinese patients with gastric cancer. J Biomed Res. 2010;24:187-197. [PMID: 23554630 DOI: 10.1016/s1674-8301(10)60028-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
40 Dai Y, Huang L, Zhang H, Hong G, He Y, Hu J, Liu Y. Differentially expressed microRNAs as diagnostic biomarkers for infected tibial non-union. Injury 2021;52:11-8. [PMID: 32972721 DOI: 10.1016/j.injury.2020.09.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Segura MF, Belitskaya-Lévy I, Rose AE, Zakrzewski J, Gaziel A, Hanniford D, Darvishian F, Berman RS, Shapiro RL, Pavlick AC, Osman I, Hernando E. Melanoma MicroRNA signature predicts post-recurrence survival. Clin Cancer Res 2010;16:1577-86. [PMID: 20179230 DOI: 10.1158/1078-0432.CCR-09-2721] [Cited by in Crossref: 162] [Cited by in F6Publishing: 79] [Article Influence: 13.5] [Reference Citation Analysis]
42 Taurino C, Miller WH, McBride MW, McClure JD, Khanin R, Moreno MU, Dymott JA, Delles C, Dominiczak AF. Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond) 2010;119:335-43. [PMID: 20528768 DOI: 10.1042/CS20100043] [Cited by in Crossref: 92] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
43 Xiao F, Liu B, Zhu QX. c-Jun N-terminal kinase is required for thermotherapy-induced apoptosis in human gastric cancer cells. World J Gastroenterol 2012; 18(48): 7348-7356 [PMID: 23326144 DOI: 10.3748/wjg.v18.i48.7348] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
44 Huang Z, Xu Y, Wan M, Zeng X, Wu J. miR-340: A multifunctional role in human malignant diseases. Int J Biol Sci 2021;17:236-46. [PMID: 33390846 DOI: 10.7150/ijbs.51123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Zheng R, Pan L, Gao J, Ye X, Chen L, Zhang X, Tang W, Zheng W. Prognostic value of miR-106b expression in breast cancer patients. J Surg Res 2015;195:158-65. [PMID: 25619461 DOI: 10.1016/j.jss.2014.12.035] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
46 Zhi F, Zhou G, Shao N, Xia X, Shi Y, Wang Q, Zhang Y, Wang R, Xue L, Wang S, Wu S, Peng Y, Yang Y. miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTK. PLoS One 2013;8:e72390. [PMID: 24013584 DOI: 10.1371/journal.pone.0072390] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
47 Zhang H, Ren Y, Xu H, Pang D, Duan C, Liu C. The expression of stem cell protein Piwil2 and piR-932 in breast cancer. Surg Oncol 2013;22:217-23. [PMID: 23992744 DOI: 10.1016/j.suronc.2013.07.001] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 8.4] [Reference Citation Analysis]
48 Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z, Cheng J, Xiao BX. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl). 2010;88:709-717. [PMID: 20349219 DOI: 10.1007/s00109-010-0617-2] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 8.8] [Reference Citation Analysis]
49 Wang S, Wang X, Weng Z, Zhang S, Ning H, Li B. Expression and role of microRNA 18b and hypoxia inducible factor-1α in placental tissues of preeclampsia patients. Exp Ther Med 2017;14:4554-60. [PMID: 29104664 DOI: 10.3892/etm.2017.5067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
50 Ahmad A, Ginnebaugh KR, Sethi S, Chen W, Ali R, Mittal S, Sarkar FH. miR-20b is up-regulated in brain metastases from primary breast cancers. Oncotarget 2015;6:12188-95. [PMID: 25893380 DOI: 10.18632/oncotarget.3664] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
51 Li J, Zhang Y, Wang X, Zhao R. microRNA-497 overexpression decreases proliferation, migration and invasion of human retinoblastoma cells via targeting vascular endothelial growth factor A. Oncol Lett 2017;13:5021-7. [PMID: 28588740 DOI: 10.3892/ol.2017.6083] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
52 Miyoshi J, Toden S, Yoshida K, Toiyama Y, Alberts SR, Kusunoki M, Sinicrope FA, Goel A. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer. Sci Rep. 2017;7:43393. [PMID: 28262692 DOI: 10.1038/srep43393] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
53 Park S, Kim J, Eom K, Oh S, Kim S, Kim G, Ahn S, Park KH, Chung D, Lee H. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer. BMC Cancer 2019;19:419. [PMID: 31060525 DOI: 10.1186/s12885-019-5620-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
54 Mushtaq F, Zhang J, Li J. miR-144 suppresses cell proliferation and invasion in gastric cancer through downregulation of activating enhancer-binding protein 4. Oncol Lett 2019;17:5686-92. [PMID: 31186793 DOI: 10.3892/ol.2019.10214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
55 Chang KH, Miller N, Kheirelseid EA, Lemetre C, Ball GR, Smith MJ, Regan M, McAnena OJ, Kerin MJ. MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease. Int J Colorectal Dis. 2011;26:1415-1422. [PMID: 21739196 DOI: 10.1007/s00384-011-1279-4] [Cited by in Crossref: 64] [Cited by in F6Publishing: 73] [Article Influence: 5.8] [Reference Citation Analysis]
56 Li LZ, Deng HX, Lou WZ, Sun XY, Song MW, Tao J, Xiao BX, Guo JM. Growth inhibitory effect of 4-phenyl butyric acid on human gastric cancer cells is associated with cell cycle arrest. World J Gastroenterol 2012; 18(1): 79-83 [PMID: 22228974 DOI: 10.3748/wjg.v18.i1.79] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
57 Xie C, Xu LY, Liu GM, Yang Z, Lv NH. Role of miRNAs in the pathogenesis of Helicobacter pylori infection. Shijie Huaren Xiaohua Zazhi 2011; 19(21): 2257-2261 [DOI: 10.11569/wcjd.v19.i21.2257] [Reference Citation Analysis]
58 Wen D, Li S, Ji F, Cao H, Jiang W, Zhu J, Fang X. miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer. Tumour Biol 2013;34:793-803. [PMID: 23296701 DOI: 10.1007/s13277-012-0609-7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
59 Chen X, Wang Y, Xing A, Xiang S, Shi D, Liu L, Li Y, Gao P. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer: SPIN1 and miR-489 in regulation of breast cancer chemosensitivity. J Pathol 2016;239:459-72. [DOI: 10.1002/path.4743] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 10.2] [Reference Citation Analysis]
60 Nie C, Han J, Bi W, Qiu Z, Chen L, Yu J, Pang R, Liu B, Sheng R, Zhang J. Circular RNA circ_0000644 promotes papillary thyroid cancer progression via sponging miR-1205 and regulating E2F3 expression. Cell Cycle 2021;:1-14. [PMID: 34919034 DOI: 10.1080/15384101.2021.2012334] [Reference Citation Analysis]
61 Hou J, Zhuo H, Chen X, Cheng J, Zheng W, Zhong M, Cai J. MiR-139-5p negatively regulates PMP22 to repress cell proliferation by targeting the NF-κB signaling pathway in gastric cancer. Int J Biol Sci 2020;16:1218-29. [PMID: 32174796 DOI: 10.7150/ijbs.40338] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
62 Peng Y, Qin Y, Zhang X, Deng S, Yuan Y, Feng X, Chen W, Hu F, Gao Y, He J, Cheng Y, Wei Y, Fan X, Ashktorab H, Smoot D, Li S, Meltzer SJ, Zhuang S, Tang N, Jin Z. MiRNA-20b/SUFU/Wnt axis accelerates gastric cancer cell proliferation, migration and EMT. Heliyon 2021;7:e06695. [PMID: 33912703 DOI: 10.1016/j.heliyon.2021.e06695] [Reference Citation Analysis]
63 Xiao X, Zhang Y, Pan W, Chen F. miR-139-mediated NOTCH1 regulation is crucial for the inhibition of osteosarcoma progression caused by resveratrol. Life Sciences 2020;242:117215. [DOI: 10.1016/j.lfs.2019.117215] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
64 Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer. 2010;126:1166-1176. [PMID: 19676045 DOI: 10.1002/ijc.24827] [Cited by in Crossref: 50] [Cited by in F6Publishing: 287] [Article Influence: 4.2] [Reference Citation Analysis]
65 Hui W, Yuntao L, Lun L, WenSheng L, ChaoFeng L, HaiYong H, Yueyang B. MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PLoS One 2013;8:e54932. [PMID: 23383003 DOI: 10.1371/journal.pone.0054932] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 6.9] [Reference Citation Analysis]
66 Mohammadian F, Abhari A, Dariushnejad H, Nikanfar A, Pilehvar-Soltanahmadi Y, Zarghami N. Effects of Chrysin-PLGA-PEG Nanoparticles on Proliferation and Gene Expression of miRNAs in Gastric Cancer Cell Line. Iran J Cancer Prev 2016;9:e4190. [PMID: 27761206 DOI: 10.17795/ijcp-4190] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
67 Shuang Y, Li C, Zhou X, Huang Y, Zhang L. MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1. Oncol Rep 2017;38:2155-65. [PMID: 28791411 DOI: 10.3892/or.2017.5875] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
68 Wentz-Hunter KK, Potashkin JA. The Role of miRNAs as Key Regulators in the Neoplastic Microenvironment. Mol Biol Int 2011;2011:839872. [PMID: 22091413 DOI: 10.4061/2011/839872] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
69 Liu J, Liu F, Shi Y, Tan H, Zhou L. Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database. FEBS Open Bio 2018;8:279-94. [PMID: 29435418 DOI: 10.1002/2211-5463.12365] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
70 Liu C. The role of microRNAs in tumors. Arch Pharm Res. 2013;36:1169-1177. [PMID: 23881700 DOI: 10.1007/s12272-013-0213-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
71 Bhat SA, Majid S, Rehman MU. Scenario and future prospects of microRNAs in gastric cancer: A review. Iran J Basic Med Sci 2019;22:345-52. [PMID: 31168337 DOI: 10.22038/ijbms.2019.32399.7765] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
72 Ma YY, Tao HQ. Microribonucleic acids and gastric cancer. Cancer Sci. 2012;103:620-625. [PMID: 22168593 DOI: 10.1111/j.1349-7006.2011.02185] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Li Z, Wu L, Tan W, Zhang K, Lin Q, Zhu J, Tu C, Lv X, Jiang C. MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3. Ann Hepatol 2021;23:100345. [PMID: 33812045 DOI: 10.1016/j.aohep.2021.100345] [Reference Citation Analysis]
74 Andrés-León E, Cases I, Alonso S, Rojas AM. Novel miRNA-mRNA interactions conserved in essential cancer pathways. Sci Rep 2017;7:46101. [PMID: 28387377 DOI: 10.1038/srep46101] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
75 Moltzahn F, Olshen AB, Baehner L, Peek A, Fong L, Stöppler H, Simko J, Hilton JF, Carroll P, Blelloch R. Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. Cancer Res. 2011;71:550-560. [PMID: 21098088 DOI: 10.1158/0008-5472.CAN-10-1229] [Cited by in Crossref: 216] [Cited by in F6Publishing: 115] [Article Influence: 18.0] [Reference Citation Analysis]
76 Wang YY, Ye ZY, Zhao ZS, Li L, Wang YX, Tao HQ, Wang HJ, He XJ. Clinicopathologic significance of miR-10b expression in gastric carcinoma. Hum Pathol. 2013;44:1278-1285. [PMID: 23351547 DOI: 10.1016/j.humpath.2012.10.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
77 Zhang Y, Shen WL, Shi ML, Zhang LZ, Zhang Z, Li P, Xing LY, Luo FY, Sun Q, Zheng XF, Yang X, Zhao ZH. Involvement of aberrant miR-139/Jun feedback loop in human gastric cancer. Biochim Biophys Acta 2015;1853:481-8. [PMID: 25499265 DOI: 10.1016/j.bbamcr.2014.12.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
78 Sun C, Sang M, Li S, Sun X, Yang C, Xi Y, Wang L, Zhang F, Bi Y, Fu Y, Li D. Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met. Oncotarget 2015;6:39756-92. [PMID: 26497851 DOI: 10.18632/oncotarget.5476] [Cited by in Crossref: 90] [Cited by in F6Publishing: 94] [Article Influence: 15.0] [Reference Citation Analysis]
79 Osawa S, Shimada Y, Sekine S, Okumura T, Nagata T, Fukuoka J, Tsukada K. MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples. Oncol Lett 2011;2:613-9. [PMID: 22848236 DOI: 10.3892/ol.2011.313] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
80 Asadi M, Shanehbandi D, Zafari V, Khaze V, Somi MH, Hashemzadeh S. Transcript Level of MicroRNA Processing Elements in Gastric Cancer. J Gastrointest Cancer 2019;50:855-9. [PMID: 30168106 DOI: 10.1007/s12029-018-0154-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
81 Li X, Yan X, Wang F, Yang Q, Luo X, Kong J, Ju S. Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer. J Cell Mol Med. 2019;23:2920-2932. [PMID: 30793479 DOI: 10.1111/jcmm.14200] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
82 Krist B, Florczyk U, Pietraszek-Gremplewicz K, Józkowicz A, Dulak J. The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology. Int J Endocrinol 2015;2015:281756. [PMID: 26839547 DOI: 10.1155/2015/281756] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
83 Liu H, Fan YF, Wei MX. Progress in understanding association between microRNAs and gastric cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(23): 2289-2293 [DOI: 10.11569/wcjd.v21.i23.2289] [Reference Citation Analysis]
84 Gulley ML. Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma. Exp Mol Med. 2015;47:e134. [PMID: 25613731 DOI: 10.1038/emm.2014.93] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
85 Dai S, Wang X, Li X, Cao Y. MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and regulating cell cycle in glioblastoma multiforme. Biochem Biophys Res Commun 2015;467:204-10. [PMID: 26449464 DOI: 10.1016/j.bbrc.2015.10.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
86 Kim WH, Min KT, Jeon YJ, Kwon C, Ko KH, Park PW, Hong SP, Rim KS, Kwon SW, Hwang SG, Kim NK. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene 2012;504:92-7. [DOI: 10.1016/j.gene.2012.05.014] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 7.6] [Reference Citation Analysis]
87 Chen YJ, Wu H, Zhu JM, Li XD, Luo SW, Dong L, Liu TT, Shen XZ. MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients. J Gastroenterol Hepatol 2016;31:155-63. [PMID: 26173586 DOI: 10.1111/jgh.13041] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
88 Xiong Y, Zhang L, Holloway AK, Wu X, Su L, Kebebew E. MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer. PLoS One 2011;6:e24717. [PMID: 21998631 DOI: 10.1371/journal.pone.0024717] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
89 Paiva I, Gil da Costa RM, Ribeiro J, Sousa H, Bastos MM, Faustino-Rocha A, Lopes C, Oliveira PA, Medeiros R. MicroRNA-21 expression and susceptibility to HPV-induced carcinogenesis - role of microenvironment in K14-HPV16 mice model. Life Sci 2015;128:8-14. [PMID: 25771247 DOI: 10.1016/j.lfs.2015.02.020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
90 Luo G, He K, Xia Z, Liu S, Liu H, Xiang G. Regulation of microRNA-497 expression in human cancer. Oncol Lett 2021;21:23. [PMID: 33240429 DOI: 10.3892/ol.2020.12284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
91 Wilmott JS, Zhang XD, Hersey P, Scolyer RA. The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology 2011;43:657-71. [PMID: 21876471 DOI: 10.1097/PAT.0b013e32834a7358] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
92 Crone SG, Jacobsen A, Federspiel B, Bardram L, Krogh A, Lund AH, Friis-Hansen L. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer. 2012;11:71. [PMID: 22992343 DOI: 10.1186/1476-4598-11-71] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
93 Lin CC, Mitra R, Cheng F, Zhao Z. A cross-cancer differential co-expression network reveals microRNA-regulated oncogenic functional modules. Mol Biosyst 2015;11:3244-52. [PMID: 26448606 DOI: 10.1039/c5mb00443h] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
94 Moreira FC, Dustan B, Hamoy IG, Ribeiro-Dos-Santos AM, Dos Santos AR. TargetCompare: A web interface to compare simultaneous miRNAs targets. Bioinformation. 2014;10:602-605. [PMID: 25352731 DOI: 10.6026/97320630010602] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
95 Liu Y, Zhang Y, Wen J, Liu L, Zhai X, Liu J, Pan S, Chen J, Shen H, Hu Z. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS One 2012;7:e32230. [PMID: 22393390 DOI: 10.1371/journal.pone.0032230] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
96 Qi F, Huang M, Pan Y, Liu Y, Liu J, Wen J, Xie K, Shen H, Ma H, Miao Y. A genetic variant in the promoter region of miR-106b-25 cluster predict clinical outcome of HBV-related hepatocellular carcinoma in Chinese. PLoS One. 2014;9:e85394. [PMID: 24416400 DOI: 10.1371/journal.pone.0085394] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
97 Chang H, Kim N, Park JH, Nam RH, Choi YJ, Lee HS, Yoon H, Shin CM, Park YS, Kim JM. Different microRNA expression levels in gastric cancer depending on Helicobacter pylori infection. Gut Liver. 2015;9:188-196. [PMID: 25167801 DOI: 10.5009/gnl13371] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
98 Huang L, Wang X, Wen C, Yang X, Song M, Chen J, Wang C, Zhang B, Wang L, Iwamoto A, Wang J, Liu H. Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer. Sci Rep 2015;5:13350. [PMID: 26302825 DOI: 10.1038/srep13350] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
99 Jia LF, Wei SB, Gong K, Gan YH, Yu GY. Prognostic implications of micoRNA miR-195 expression in human tongue squamous cell carcinoma. PLoS One 2013;8:e56634. [PMID: 23451060 DOI: 10.1371/journal.pone.0056634] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
100 Song MY, Pan KF, Su HJ, Zhang L, Ma JL, Li JY, Yuasa Y, Kang D, Kim YS, You WC. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One. 2012;7:e33608. [PMID: 22432036 DOI: 10.1371/journal.pone.0033608] [Cited by in Crossref: 122] [Cited by in F6Publishing: 129] [Article Influence: 12.2] [Reference Citation Analysis]
101 Ai C, Jiang R, Fu L, Chen Y. MicroRNA-495 mimics delivery inhibits lung tumor progression. Tumour Biol 2015;36:729-35. [PMID: 25286762 DOI: 10.1007/s13277-014-2687-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
102 Shi J, Gong L, Chen L, Luo J, Song G, Xu J, Lv Z, Tao H, Xia Y, Ye Z. miR-618 Suppresses Metastasis in Gastric Cancer by Downregulating the Expression of TGF-β2. Anat Rec (Hoboken) 2019;302:931-40. [PMID: 30737902 DOI: 10.1002/ar.24083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
103 Gong Y, Ren J, Liu K, Tang LM. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R. World J Gastroenterol 2015; 21(10): 2949-2958 [PMID: 25780292 DOI: 10.3748/wjg.v21.i10.2949] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
104 Park S, Eom K, Kim J, Bang H, Wang HY, Ahn S, Kim G, Jang H, Kim S, Lee D, Park KH, Lee H. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer 2017;17:658. [PMID: 28934937 DOI: 10.1186/s12885-017-3642-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 58] [Article Influence: 9.8] [Reference Citation Analysis]
105 Yang X, Wu W, Pan Y, Zhou Q, Xu J, Han S. Immune-related genes in tumor-specific CD4+ and CD8+ T cells in colon cancer. BMC Cancer 2020;20:585. [PMID: 32571262 DOI: 10.1186/s12885-020-07075-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Song H, Sun W, Ye G, Ding X, Liu Z, Zhang S, Xia T, Xiao B, Xi Y, Guo J. Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J Transl Med. 2013;11:225. [PMID: 24063685 DOI: 10.1186/1479-5876-11-225] [Cited by in Crossref: 148] [Cited by in F6Publishing: 158] [Article Influence: 16.4] [Reference Citation Analysis]
107 Masood Y, Kqueen CY, Rajadurai P. Role of miRNA in head and neck squamous cell carcinoma. Expert Review of Anticancer Therapy 2014;15:183-97. [DOI: 10.1586/14737140.2015.978294] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
108 Pietilä T, Nummi M, Auvinen P, Mannonen L, Auvinen E. Expression of BKV and JCV encoded microRNA in human cerebrospinal fluid, plasma and urine. J Clin Virol 2015;65:1-5. [PMID: 25766978 DOI: 10.1016/j.jcv.2015.01.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
109 Hummel R, Hussey DJ, Michael MZ, Haier J, Bruewer M, Senninger N, Watson DI. MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann Surg Oncol. 2011;18:253-260. [PMID: 20628822 DOI: 10.1245/s10434-010-1213-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
110 Wagner M, Vicinus B, Frick VO, Auchtor M, Rubie C, Jeanmonod P, Richards TA, Linder R, Weichert F. MicroRNA target prediction: theory and practice. Mol Genet Genomics 2014;289:1085-101. [PMID: 24938624 DOI: 10.1007/s00438-014-0871-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
111 Zhang J, Shi H, Xue M, Yu Q, Yang L, Zheng S, Zhou C. An insertion/deletion polymorphism in the interleukin-1A 3'untranslated region confers risk for gastric cancer. CBM 2016;16:359-65. [DOI: 10.3233/cbm-160574] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Cheng J, Guo JM, Xiao BX, Miao Y, Jiang Z, Zhou H, Li QN. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin Chim Acta. 2011;412:1621-1625. [PMID: 21616063 DOI: 10.1016/j.cca.2011.05.015] [Cited by in Crossref: 201] [Cited by in F6Publishing: 180] [Article Influence: 18.3] [Reference Citation Analysis]
113 An J, Liu J, Liu L, Liu Y, Pan Y, Huang M, Qi F, Wen J, Xie K, Ma H, Shen H, Hu Z. A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population. PLoS One 2014;9:e93707. [PMID: 24751683 DOI: 10.1371/journal.pone.0093707] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
114 Matsushima K, Isomoto H, Inoue N, Nakayama T, Hayashi T, Nakayama M, Nakao K, Hirayama T, Kohno S. MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer. 2011;128:361-370. [PMID: 20333682 DOI: 10.1002/ijc.25348] [Cited by in Crossref: 131] [Cited by in F6Publishing: 132] [Article Influence: 10.9] [Reference Citation Analysis]
115 Hsu TI, Hsu CH, Lee KH, Lin JT, Chen CS, Chang KC, Su CY, Hsiao M, Lu PJ. MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo. Oncogenesis 2014;3:e99. [PMID: 24752237 DOI: 10.1038/oncsis.2014.12] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 7.6] [Reference Citation Analysis]
116 Budhu A, Wang XW. MicroRNAs and Gastroenterological Cancers. Drug Discov Today Dis Mech 2011;8:e95-e102. [PMID: 22582080 DOI: 10.1016/j.ddmec.2011.11.005] [Reference Citation Analysis]
117 Ariyoshi J, Matsuyama Y, Kobori A, Murakami A, Sugiyama H, Yamayoshi A. Effective Anti-miRNA Oligonucleotides Show High Releasing Rate of MicroRNA from RNA-Induced Silencing Complex. Nucleic Acid Ther 2017;27:303-8. [PMID: 28876213 DOI: 10.1089/nat.2017.0663] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
118 Singh SS, Yap WN, Arfuso F, Kar S, Wang C, Cai W, Dharmarajan AM, Sethi G, Kumar AP. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine? World J Gastroenterol 2015; 21(43): 12261-12273 [PMID: 26604635 DOI: 10.3748/wjg.v21.i43.12261] [Cited by in CrossRef: 102] [Cited by in F6Publishing: 98] [Article Influence: 14.6] [Reference Citation Analysis]
119 Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, Lenhof HP, Ruprecht K, Meese E. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 2009;4:e7440. [PMID: 19823682 DOI: 10.1371/journal.pone.0007440] [Cited by in Crossref: 246] [Cited by in F6Publishing: 241] [Article Influence: 18.9] [Reference Citation Analysis]
120 Gits CM, van Kuijk PF, Jonkers MB, Boersma AW, van Ijcken WF, Wozniak A, Sciot R, Rutkowski P, Schöffski P, Taguchi T. MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours. Br J Cancer. 2013;109:1625-1635. [PMID: 23969726 DOI: 10.1038/bjc.2013.483] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
121 Yu X, Luo L, Wu Y, Yu X, Liu Y, Yu X, Zhao X, Zhang X, Cui L, Ye G. Gastric juice miR-129 as a potential biomarker for screening gastric cancer. Med Oncol. 2013;30:365. [PMID: 23307240 DOI: 10.1007/s12032-012-0365-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
122 Finnerty JR, Wang WX, Hébert SS, Wilfred BR, Mao G, Nelson PT. The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol. 2010;402:491-509. [PMID: 20678503 DOI: 10.1016/j.jmb.2010.07.051] [Cited by in Crossref: 248] [Cited by in F6Publishing: 256] [Article Influence: 20.7] [Reference Citation Analysis]
123 Zhang L, Li YY, Zeng HC, Wei J, Wan YJ, Chen J, Xu SQ. MicroRNA expression changes during zebrafish development induced by perfluorooctane sulfonate. J Appl Toxicol 2011;31:210-22. [PMID: 20878907 DOI: 10.1002/jat.1583] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
124 Yu DC, Li QG, Ding XW, Ding YT. Circulating MicroRNAs: Potential Biomarkers for Cancer. Int J Mol Sci. 2011;12:2055-2063. [PMID: 21673939 DOI: 10.3390/ijms12032055] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 6.1] [Reference Citation Analysis]
125 Li Z, Jiang J, Yi X, Wang G, Wang S, Sun X. miR-18b regulates the function of rabbit ovary granulosa cells. Reprod Fertil Dev 2021;33:363-71. [PMID: 33641714 DOI: 10.1071/RD20237] [Reference Citation Analysis]
126 Wu J, Li G, Yao Y, Wang Z, Sun W, Wang J. MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer. Biomarkers. 2015;20:58-63. [PMID: 25510566 DOI: 10.3109/1354750x.2014.992812] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
127 Nooh M, Hakemi-Vala M, Nowroozi J, Fatemi SR, Dezfulian M. Prediction of Blood miRNA-mRNA Regulatory Network in Gastric Cancer. Rep Biochem Mol Biol 2021;10:243-56. [PMID: 34604414 DOI: 10.52547/rbmb.10.2.243] [Reference Citation Analysis]
128 Streleckiene G, Inciuraite R, Juzenas S, Salteniene V, Steponaitiene R, Gyvyte U, Kiudelis G, Leja M, Ruzgys P, Satkauskas S, Kupcinskiene E, Franke S, Thon C, Link A, Kupcinskas J, Skieceviciene J. miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model. Int J Mol Sci 2020;21:E877. [PMID: 32013265 DOI: 10.3390/ijms21030877] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
129 Damodaran C, Das TP, Papu John AM, Suman S, Kolluru V, Morris TJ, Faber EN, Rai SN, Messer JC, Alatassi H, Ankem MK. miR-301a expression: A prognostic marker for prostate cancer. Urol Oncol 2016;34:336.e13-20. [PMID: 27133223 DOI: 10.1016/j.urolonc.2016.03.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
130 Wen X, Han XR, Wang YJ, Wang S, Shen M, Zhang ZF, Fan SH, Shan Q, Wang L, Li MQ, Hu B, Sun CH, Wu DM, Lu J, Zheng YL. MicroRNA-421 suppresses the apoptosis and autophagy of hippocampal neurons in epilepsy mice model by inhibition of the TLR/MYD88 pathway. J Cell Physiol 2018;233:7022-34. [PMID: 29380367 DOI: 10.1002/jcp.26498] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
131 Li CY, Liang GY, Yao WZ, Sui J, Shen X, Zhang YQ, Peng H, Hong WW, Ye YC, Zhang ZY, Zhang WH, Yin LH, Pu YP. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression. Clin Transl Oncol 2017;19:162-72. [PMID: 27173517 DOI: 10.1007/s12094-016-1516-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
132 Chen W, Yang Y, Chen B, Lu P, Zhan L, Yu Q, Cao K, Li Q. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells. J Neurooncol 2014;120:43-53. [DOI: 10.1007/s11060-014-1535-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
133 Zhang R, Li F, Wang W, Wang X, Li S, Liu J. The effect of antisense inhibitor of miRNA 106b∼25 on the proliferation, invasion, migration, and apoptosis of gastric cancer cell. Tumour Biol 2016;37:10507-15. [PMID: 26850596 DOI: 10.1007/s13277-016-4937-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
134 Zhang Y, Duan G, Feng S. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1. Biochem Biophys Res Commun 2015;459:367-73. [PMID: 25727016 DOI: 10.1016/j.bbrc.2015.02.101] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
135 Shen Z, Zhan G, Deng H, Ren Y, Ye D, Xiao B, Guo J. MicroRNA-519a demonstrates significant tumour suppressive activity in laryngeal squamous cells by targeting anti-carcinoma HuR gene. J Laryngol Otol 2013;127:1194-202. [DOI: 10.1017/s0022215113003174] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
136 Pan J, Lu F, Xu H, Wang Q, Lin C, Zhang S. Low p21 level is necessary for the suppressive effects of micoRNA-31 on glioma cell migration and invasion. Tumour Biol 2016;37:9663-70. [PMID: 26801671 DOI: 10.1007/s13277-016-4788-5] [Reference Citation Analysis]
137 Zhang Z, Li Z, Li Y, Zang A. MicroRNA and signaling pathways in gastric cancer. Cancer Gene Ther 2014;21:305-16. [PMID: 25060632 DOI: 10.1038/cgt.2014.37] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
138 Xie Y, Wei RR, Huang GL, Zhang MY, Yuan YF, Wang HY. Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma. Med Oncol 2014;31:844. [PMID: 24464213 DOI: 10.1007/s12032-014-0844-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
139 Link A, Kupcinskas J, Wex T, Malfertheiner P. Macro-role of microRNA in gastric cancer. Dig Dis. 2012;30:255-267. [PMID: 22722550 DOI: 10.1159/000336919] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
140 Zhao Y, Huang J, Zhang L, Qu Y, Li J, Yu B, Yan M, Yu Y, Liu B, Zhu Z. MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells. BMC Cancer. 2014;14:34. [PMID: 24443799 DOI: 10.1186/1471-2407-14-34] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
141 Sánchez-Jiménez C, Carrascoso I, Barrero J, Izquierdo JM. Identification of a set of miRNAs differentially expressed in transiently TIA-depleted HeLa cells by genome-wide profiling. BMC Mol Biol 2013;14:4. [PMID: 23387986 DOI: 10.1186/1471-2199-14-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
142 Hiroki E, Akahira J, Suzuki F, Nagase S, Ito K, Suzuki T, Sasano H, Yaegashi N. Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci 2010;101:241-9. [PMID: 19891660 DOI: 10.1111/j.1349-7006.2009.01385.x] [Cited by in Crossref: 148] [Cited by in F6Publishing: 139] [Article Influence: 11.4] [Reference Citation Analysis]
143 Edmonds MD, Boyd KL, Moyo T, Mitra R, Duszynski R, Arrate MP, Chen X, Zhao Z, Blackwell TS, Andl T, Eischen CM. MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer. J Clin Invest 2016;126:349-64. [PMID: 26657862 DOI: 10.1172/JCI82720] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 8.1] [Reference Citation Analysis]
144 Zhang R, Wang W, Li F, Zhang H, Liu J. MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers. Med Oncol. 2014;31:243. [PMID: 25218271 DOI: 10.1007/s12032-014-0243-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
145 Xu Q, Dong QG, Sun LP, He CY, Yuan Y. Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study. BMC Clin Pathol. 2013;13:11. [PMID: 23521833 DOI: 10.1186/1472-6890-13-11] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
146 Liu D, Hu X, Zhou H, Shi G, Wu J. Identification of Aberrantly Expressed miRNAs in Gastric Cancer. Gastroenterol Res Pract. 2014;2014:473817. [PMID: 24982669 DOI: 10.1155/2014/473817] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
147 Li H, Wu Q, Li T, Liu C, Xue L, Ding J, Shi Y, Fan D. The miR-17-92 cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review. Oncotarget 2017;8:45060-71. [PMID: 28178677 DOI: 10.18632/oncotarget.15023] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
148 Shirmohammadi K, Sohrabi S, Jafarzadeh Samani Z, Effatpanah H, Yadegarazari R, Saidijam M. Evaluation of altered expression of miR-9 and miR-106a as an early diagnostic approach in gastric cancer. J Gastrointest Oncol 2018;9:46-51. [PMID: 29564170 DOI: 10.21037/jgo.2017.11.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
149 Gao M, Liu L, Yang Y, Li M, Ma Q, Chang Z. LncRNA HCP5 Induces Gastric Cancer Cell Proliferation, Invasion, and EMT Processes Through the miR-186-5p/WNT5A Axis Under Hypoxia. Front Cell Dev Biol 2021;9:663654. [PMID: 34178988 DOI: 10.3389/fcell.2021.663654] [Reference Citation Analysis]
150 Kim YJ, Hwang KC, Kim SW, Lee YC. Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia. Int J Med Sci 2018;15:610-6. [PMID: 29725252 DOI: 10.7150/ijms.24061] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
151 Zhou Y, Wang Y, Wang L, Zhang J, Liu X. Decreased microRNA-768-3p expression indicates a poor prognosis in patients with breast cancer and promotes breast cancer cell viability, migration and invasion. Oncol Lett 2021;22:579. [PMID: 34122630 DOI: 10.3892/ol.2021.12840] [Reference Citation Analysis]
152 Wang G, Liu G, Ye Y, Fu Y, Zhang X. Upregulation of miR-34a by diallyl disulfide suppresses invasion and induces apoptosis in SGC-7901 cells through inhibition of the PI3K/Akt signaling pathway. Oncol Lett 2016;11:2661-7. [PMID: 27073535 DOI: 10.3892/ol.2016.4266] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
153 Asghari Alashti F, Minuchehr Z. MiRNAs which target CD3 subunits could be potential biomarkers for cancers. PLoS One 2013;8:e78790. [PMID: 24244363 DOI: 10.1371/journal.pone.0078790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
154 Wu Q, Yang Z, An Y, Hu H, Yin J, Zhang P, Nie Y, Wu K, Shi Y, Fan D. MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1. Cell Death Dis. 2014;5:e1144. [PMID: 24675462 DOI: 10.1038/cddis.2014.110] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 9.3] [Reference Citation Analysis]
155 Avissar M, McClean MD, Kelsey KT, Marsit CJ. MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 2009;30:2059-63. [PMID: 19901002 DOI: 10.1093/carcin/bgp277] [Cited by in Crossref: 109] [Cited by in F6Publishing: 103] [Article Influence: 9.1] [Reference Citation Analysis]
156 Ma C, Miao C, Wang C, Song F, Luo M. PELP1 is a novel oncogene in gastric tumorigenesis and negatively regulated by miR-15 family microRNAs. Cancer Biomark 2019;26:1-9. [PMID: 31322541 DOI: 10.3233/CBM-182279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
157 Paul S, Vera J. Rough hypercuboid based supervised clustering of miRNAs. Mol Biosyst 2015;11:2068-81. [PMID: 25996345 DOI: 10.1039/c5mb00213c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
158 Liao M, Jiang W, Chen X, Lian B, Li W, Lv Y, Wang Y, Wang S, Li X. Systematic analysis of regulation and functions of co-expressed microRNAs in humans. Mol Biosyst 2010;6:1863-72. [PMID: 20548996 DOI: 10.1039/b926947a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
159 Yoshimoto N, Toyama T, Takahashi S, Sugiura H, Endo Y, Iwasa M, Fujii Y, Yamashita H. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer. Breast Cancer Res Treat 2011;130:331-9. [PMID: 21755340 DOI: 10.1007/s10549-011-1672-2] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 5.7] [Reference Citation Analysis]
160 Lee J, Kang H. Hypoxia Promotes Vascular Smooth Muscle Cell Proliferation through microRNA-Mediated Suppression of Cyclin-Dependent Kinase Inhibitors. Cells 2019;8:E802. [PMID: 31370272 DOI: 10.3390/cells8080802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
161 Lu J, Zhang M, Yang X, Cui T, Dai J. MicroRNA-548c-3p inhibits T98G glioma cell proliferation and migration by downregulating c-Myb. Oncol Lett 2017;13:3866-72. [PMID: 28536644 DOI: 10.3892/ol.2017.5870] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
162 Ye J, Cheng XD, Cheng B, Cheng YF, Chen XJ, Lu WG. MiRNA detection in cervical exfoliated cells for missed high-grade lesions in women with LSIL/CIN1 diagnosis after colposcopy-guided biopsy. BMC Cancer 2019;19:112. [PMID: 30700264 DOI: 10.1186/s12885-019-5311-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
163 Yang Z, Xie C, Xu W, Liu G, Cao X, Li W, Chen J, Zhu Y, Luo S, Luo Z, Lu N. Phosphorylation and inactivation of PTEN at residues Ser380/Thr382/383 induced by Helicobacter pylori promotes gastric epithelial cell survival through PI3K/Akt pathway. Oncotarget 2015;6:31916-26. [PMID: 26376616 DOI: 10.18632/oncotarget.5577] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
164 Yang G, Xiong G, Cao Z, Zheng S, You L, Zhang T, Zhao Y. miR-497 expression, function and clinical application in cancer. Oncotarget. 2016;7:55900-55911. [PMID: 27344185 DOI: 10.18632/oncotarget.10152] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
165 Wu Y, Wan X, Ji F, Song Z, Fang X. Serum miR-658 induces metastasis of gastric cancer by activating PAX3-MET pathway: A population-based study. CBM 2018;22:111-8. [DOI: 10.3233/cbm-171045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
166 Gao M, Yin H, Fei ZW. Clinical application of microRNA in gastric cancer in Eastern Asian area. World J Gastroenterol 2013; 19(13): 2019-2027 [PMID: 23599620 DOI: 10.3748/wjg.v19.i13.2019] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
167 Wang S, Wu J, Ren J, Vlantis AC, Li MY, Liu SYW, Ng EKW, Chan ABW, Luo DC, Liu Z, Guo W, Xue L, Ng SK, van Hasselt CA, Tong MCF, Chen GG. MicroRNA-125b Interacts with Foxp3 to Induce Autophagy in Thyroid Cancer. Mol Ther 2018;26:2295-303. [PMID: 30005868 DOI: 10.1016/j.ymthe.2018.06.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
168 Shi Z, Kadeer A, Wang M, Wen B, Li M, Huang J, Gao Y, Liu E, Liu D, Jia D, Liang C. The deregulation of miR-133b is associated with poor prognosis in bladder cancer. Pathology - Research and Practice 2019;215:354-7. [DOI: 10.1016/j.prp.2018.11.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
169 Xu XD, He XJ, Tao HQ, Zhang W, Wang YY, Ye ZY, Zhao ZS. Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis. J Surg Oncol. 2013;108:197-202. [PMID: 23832550 DOI: 10.1002/jso.23374] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
170 Jin Z, Selaru FM, Cheng Y, Kan T, Agarwal R, Mori Y, Olaru AV, Yang J, David S, Hamilton JP. MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene. 2011;30:1577-1585. [PMID: 21119604 DOI: 10.1038/onc.2010.534] [Cited by in Crossref: 82] [Cited by in F6Publishing: 89] [Article Influence: 6.8] [Reference Citation Analysis]
171 Zeng X, Li J, Li S. A functional polymorphism in IL-1A gene is associated with a reduced risk of gastric cancer. Tumor Biol 2014;35:265-8. [DOI: 10.1007/s13277-013-1034-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
172 Yungang W, Xiaoyu L, Pang T, Wenming L, Pan X. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC). Biomed Pharmacother 2014;68:149-54. [PMID: 24055400 DOI: 10.1016/j.biopha.2013.08.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
173 Cui L, Lou Y, Zhang X, Zhou H, Deng H, Song H, Yu X, Xiao B, Wang W, Guo J. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers. Clin Biochem. 2011;44:1050-1057. [PMID: 21704610 DOI: 10.1016/j.clinbiochem.2011.06.004] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 9.5] [Reference Citation Analysis]
174 Guo X, Guo L, Ji J, Zhang J, Zhang J, Chen X, Cai Q, Li J, Gu Q, Liu B, Zhu Z, Yu Y. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem Biophys Res Commun. 2010;398:1-6. [PMID: 20510161 DOI: 10.1016/j.bbrc.2010.05.082] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 6.5] [Reference Citation Analysis]
175 Wang Y, Zhang X, Zou C, Kung H, Lin MC, Dress A, Wardle F, Jiang B, Lai L. miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancer. Biomedicine & Pharmacotherapy 2016;80:95-101. [DOI: 10.1016/j.biopha.2016.03.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
176 Deng K, Wang H, Guo X, Xia J. The cross talk between long, non-coding RNAs and microRNAs in gastric cancer. Acta Biochim Biophys Sin (Shanghai) 2016;48:111-6. [PMID: 26621794 DOI: 10.1093/abbs/gmv120] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
177 Wei J, Wang J, Gao X, Qi F. Identification of differentially expressed circRNAs and a novel hsa_circ_0000144 that promote tumor growth in gastric cancer. Cancer Cell Int 2019;19:268. [PMID: 31636511 DOI: 10.1186/s12935-019-0975-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
178 Furuta M, Kozaki K, Tanimoto K, Tanaka S, Arii S, Shimamura T, Niida A, Miyano S, Inazawa J. The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma. PLoS One. 2013;8:e60155. [PMID: 23544130 DOI: 10.1371/journal.pone.0060155] [Cited by in Crossref: 93] [Cited by in F6Publishing: 102] [Article Influence: 10.3] [Reference Citation Analysis]
179 Yan Y, Wang LF, Wang RF. Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer. World J Gastroenterol 2015; 21(33): 9717-9726 [PMID: 26361418 DOI: 10.3748/wjg.v21.i33.9717] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 44] [Article Influence: 5.7] [Reference Citation Analysis]
180 Hua Y, Larsen N, Kalyana-Sundaram S, Kjems J, Chinnaiyan AM, Peter ME. miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers. BMC Genomics 2013;14:179. [PMID: 23497354 DOI: 10.1186/1471-2164-14-179] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
181 Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H, Okamoto K, Otsuji E. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer. 2010;102:1174-1179. [PMID: 20234369 DOI: 10.1038/sj.bjc.6605608] [Cited by in Crossref: 437] [Cited by in F6Publishing: 431] [Article Influence: 36.4] [Reference Citation Analysis]
182 Dar AA, Majid S, Rittsteuer C, de Semir D, Bezrookove V, Tong S, Nosrati M, Sagebiel R, Miller JR 3rd, Kashani-Sabet M. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst 2013;105:433-42. [PMID: 23365201 DOI: 10.1093/jnci/djt003] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 7.8] [Reference Citation Analysis]
183 Paul S, Maji P. Rough sets for in silico identification of differentially expressed miRNAs. Int J Nanomedicine 2013;8 Suppl 1:63-74. [PMID: 24098080 DOI: 10.2147/IJN.S40739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
184 He JF, Luo YM, Wan XH, Jiang D. Biogenesis of MiRNA-195 and its role in biogenesis, the cell cycle, and apoptosis. J Biochem Mol Toxicol. 2011;25:404-408. [PMID: 22190509 DOI: 10.1002/jbt.20396] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 7.7] [Reference Citation Analysis]
185 Hamfjord J, Stangeland AM, Hughes T, Skrede ML, Tveit KM, Ikdahl T, Kure EH. Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing. PLoS One. 2012;7:e34150. [PMID: 22529906 DOI: 10.1371/journal.pone.0034150] [Cited by in Crossref: 107] [Cited by in F6Publishing: 106] [Article Influence: 10.7] [Reference Citation Analysis]
186 Zhang X, Cui L, Ye G, Zheng T, Song H, Xia T, Yu X, Xiao B, Le Y, Guo J. Gastric juice microRNA-421 is a new biomarker for screening gastric cancer. Tumour Biol. 2012;33:2349-2355. [PMID: 22926798 DOI: 10.1007/s13277-012-0497-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
187 Xie G, Ke Q, Ji YZ, Wang AQ, Jing M, Zou LL. FGFR1 is an independent prognostic factor and can be regulated by miR-497 in gastric cancer progression. Braz J Med Biol Res 2018;52:e7816. [PMID: 30484492 DOI: 10.1590/1414-431X20187816] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
188 Zhou H, Xiao B, Zhou F, Deng H, Zhang X, Lou Y, Gong Z, Du C, Guo J. MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients. Biomarkers. 2012;17:104-110. [PMID: 22263628 DOI: 10.3109/1354750x.2011.614961] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
189 Lindberg RL, Hoffmann F, Mehling M, Kuhle J, Kappos L. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. Eur J Immunol 2010;40:888-98. [PMID: 20148420 DOI: 10.1002/eji.200940032] [Cited by in Crossref: 138] [Cited by in F6Publishing: 140] [Article Influence: 11.5] [Reference Citation Analysis]
190 Cui BH, Hong X. miR-6852 serves as a prognostic biomarker in colorectal cancer and inhibits tumor growth and metastasis by targeting TCF7. Exp Ther Med 2018;16:879-85. [PMID: 30116340 DOI: 10.3892/etm.2018.6259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
191 Matsuyama Y, Yamayoshi A, Kobori A, Murakami A. Functional regulation of RNA-induced silencing complex by photoreactive oligonucleotides. Bioorg Med Chem 2014;22:1003-7. [PMID: 24417957 DOI: 10.1016/j.bmc.2013.12.044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
192 Huang LL, Huang LW, Wang L, Tong BD, Wei Q, Ding XS. Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy. Oncol Lett 2017;14:1215-22. [PMID: 28789336 DOI: 10.3892/ol.2017.6351] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
193 Li Z, Cao Y, Jie Z, Liu Y, Li Y, Li J, Zhu G, Liu Z, Tu Y, Peng G. miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Lett. 2012;323:41-47. [PMID: 22469786 DOI: 10.1016/j.canlet.2012.03.029] [Cited by in Crossref: 68] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
194 da Silva Oliveira KC, Thomaz Araújo TM, Albuquerque CI, Barata GA, Gigek CO, Leal MF, Wisnieski F, Rodrigues Mello Junior FA, Khayat AS, de Assumpção PP, Rodriguez Burbano RM, Smith MC, Calcagno DQ. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer. World J Gastroenterol 2016; 22(35): 7951-7962 [PMID: 27672290 DOI: 10.3748/wjg.v22.i35.7951] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
195 Lim WK, Micklem G. MicroRNAs dysregulated in breast cancer preferentially target key oncogenic pathways. Mol Biosyst 2011;7:2571-6. [PMID: 21766137 DOI: 10.1039/c1mb05181d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
196 Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi Y, Guo J. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci Rep. 2014;4:6088. [PMID: 25124853 DOI: 10.1038/srep06088] [Cited by in Crossref: 228] [Cited by in F6Publishing: 267] [Article Influence: 28.5] [Reference Citation Analysis]
197 Hu Y, Tian H, Xu J, Fang JY. Roles of competing endogenous RNAs in gastric cancer. Brief Funct Genomics. 2016;15:266-273. [PMID: 26404556 DOI: 10.1093/bfgp/elv036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
198 Zhao F, Dou Y, Wang X, Han D, Lv Z, Ge S, Zhang Y. Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer. Mol Biol Rep 2014;41:5913-22. [DOI: 10.1007/s11033-014-3466-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
199 Asangani IA, Harms PW, Dodson L, Pandhi M, Kunju LP, Maher CA, Fullen DR, Johnson TM, Giordano TJ, Palanisamy N, Chinnaiyan AM. Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma. Oncotarget 2012;3:1011-25. [PMID: 22948084 DOI: 10.18632/oncotarget.622] [Cited by in Crossref: 106] [Cited by in F6Publishing: 95] [Article Influence: 11.8] [Reference Citation Analysis]
200 Yin Y, Li J, Chen S, Zhou T, Si J. MicroRNAs as Diagnostic Biomarkers in Gastric Cancer. Int J Mol Sci. 2012;13:12544-12555. [PMID: 23202912 DOI: 10.3390/ijms131012544] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
201 Han X, Zhang Y, Wang D, Fu X, Li M, Wang A. Upregulation of microRNA-18b induces phosphatase and tensin homolog to accelerate the migration and invasion abilities of ovarian cancer. Oncol Lett 2017;14:5631-7. [PMID: 29142608 DOI: 10.3892/ol.2017.6854] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
202 Song B, Du J, Song DF, Ren JC, Feng Y. Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer. Biol Res 2018;51:44. [PMID: 30390708 DOI: 10.1186/s40659-018-0192-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
203 Turai PI, Nyírő G, Butz H, Patócs A, Igaz P. MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in Pheochromocytoma/Paraganglioma. Cancers (Basel) 2021;13:1522. [PMID: 33810219 DOI: 10.3390/cancers13071522] [Reference Citation Analysis]
204 Hayashi Y, Tsujii M, Wang J, Kondo J, Akasaka T, Jin Y, Li W, Nakamura T, Nishida T, Iijima H. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut. 2013;62:1536-1546. [PMID: 22936674 DOI: 10.1136/gutjnl-2011-301625] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 8.0] [Reference Citation Analysis]
205 Wang L, Steele I, Kumar JD, Dimaline R, Jithesh PV, Tiszlavicz L, Reisz Z, Dockray GJ, Varro A. Distinct miRNA profiles in normal and gastric cancer myofibroblasts and significance in Wnt signaling. Am J Physiol Gastrointest Liver Physiol 2016;310:G696-704. [PMID: 26939869 DOI: 10.1152/ajpgi.00443.2015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
206 Rashad NM, El-Shal AS, Shalaby SM, Mohamed SY. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma. Mol Cell Biochem 2018;447:125-36. [PMID: 29455432 DOI: 10.1007/s11010-018-3298-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
207 Mohammadi Yeganeh S, Vasei M, Tavakoli R, Kia V, Paryan M. The effect of miR-340 over-expression on cell-cycle-related genes in triple-negative breast cancer cells. Eur J Cancer Care 2017;26:e12496. [DOI: 10.1111/ecc.12496] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
208 Noto JM, Peek RM. The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis. Front Cell Infect Microbiol. 2011;1:21. [PMID: 22919587 DOI: 10.3389/fcimb.2011.00021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
209 Ariyoshi J, Momokawa D, Eimori N, Kobori A, Murakami A, Yamayoshi A. Development of Novel Antisense Oligonucleotides for the Functional Regulation of RNA-Induced Silencing Complex (RISC) by Promoting the Release of microRNA from RISC. Bioconjug Chem 2015;26:2454-60. [PMID: 26471458 DOI: 10.1021/acs.bioconjchem.5b00501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
210 Zhang Y, Bai J, Si W, Yuan S, Li Y, Chen X. SLC39A7, regulated by miR-139-5p, induces cell proliferation, migration and inhibits apoptosis in gastric cancer via Akt/mTOR signaling pathway. Biosci Rep 2020;40:BSR20200041. [PMID: 32109290 DOI: 10.1042/BSR20200041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
211 Jafari N, Abediankenari S. MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell. Tumour Biol 2017;39:1010428317701652. [PMID: 28468587 DOI: 10.1177/1010428317701652] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
212 Lopez-Camarillo C, Marchat LA, Arechaga-Ocampo E, Perez-Plasencia C, Del Moral-Hernandez O, Castaneda-Ortiz EJ, Rodriguez-Cuevas S. MetastamiRs: Non-Coding MicroRNAs Driving Cancer Invasion and Metastasis. Int J Mol Sci. 2012;13:1347-1379. [PMID: 22408395 DOI: 10.3390/ijms13021347] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
213 Zhang W, Jiang H, Chen Y, Ren F. Resveratrol chemosensitizes adriamycin-resistant breast cancer cells by modulating miR-122-5p. J Cell Biochem 2019;120:16283-92. [PMID: 31155753 DOI: 10.1002/jcb.28910] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
214 Xia JT, Chen LZ, Jian WH, Wang KB, Yang YZ, He WL, He YL, Chen D, Li W. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling. J Transl Med. 2014;12:33. [PMID: 24495516 DOI: 10.1186/1479-5876-12-33] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 8.0] [Reference Citation Analysis]
215 Wang K, Zhou LY, Wang JX, Wang Y, Sun T, Zhao B, Yang YJ, An T, Long B, Li N, Liu CY, Gong Y, Gao JN, Dong YH, Zhang J, Li PF. E2F1-dependent miR-421 regulates mitochondrial fragmentation and myocardial infarction by targeting Pink1. Nat Commun 2015;6:7619. [PMID: 26184432 DOI: 10.1038/ncomms8619] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 7.9] [Reference Citation Analysis]
216 Fuse M, Kojima S, Enokida H, Chiyomaru T, Yoshino H, Nohata N, Kinoshita T, Sakamoto S, Naya Y, Nakagawa M, Ichikawa T, Seki N. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer. J Hum Genet 2012;57:691-9. [PMID: 22854542 DOI: 10.1038/jhg.2012.95] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 7.6] [Reference Citation Analysis]
217 Zhu F, Wu Q, Ni Z, Lei C, Li T, Shi Y. miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells. Int J Mol Med. 2018;42:228-236. [PMID: 29568890 DOI: 10.3892/ijmm.2018.3581] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
218 Xiao C, Hong H, Yu H, Yuan J, Guo C, Cao H, Li W. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway. Immunopharmacology and Immunotoxicology 2018;40:278-83. [DOI: 10.1080/08923973.2018.1455208] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
219 Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Prostate. 2013;73:827-834. [PMID: 23184537 DOI: 10.1002/pros.22626] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
220 Bittoni A, Piva F, Santoni M, Andrikou K, Conti A, Loretelli C, Mandolesi A, Lanese A, Pellei C, Scarpelli M, Principato G, Cascinu S. KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma. Future Oncol 2015;11:1905-17. [PMID: 26161927 DOI: 10.2217/fon.15.98] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
221 Albulescu R, Neagu M, Albulescu L, Tanase C. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers. Expert Rev Mol Diagn. 2011;11:101-120. [PMID: 21171925 DOI: 10.1586/erm.10.106] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
222 Zhang X, Peng Y, Jin Z, Huang W, Cheng Y, Liu Y, Feng X, Yang M, Huang Y, Zhao Z. Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma. Oncotarget. 2015;6:32878-32889. [PMID: 26460735 DOI: 10.18632/oncotarget.5419] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
223 Zhu Y, Ortiz A, Costa M. Wrong place, wrong time: Runt-related transcription factor 2/SATB2 pathway in bone development and carcinogenesis. J Carcinog 2021;20:2. [PMID: 34211338 DOI: 10.4103/jcar.JCar_22_20] [Reference Citation Analysis]
224 Law IKM, Padua DM, Iliopoulos D, Pothoulakis C. Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology. Am J Physiol Gastrointest Liver Physiol 2017;313:G361-72. [PMID: 28774868 DOI: 10.1152/ajpgi.00144.2017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
225 Kim JG, Kim TO, Bae JH, Shim JW, Kang MJ, Yang K, Ting AH, Yi JM. Epigenetically regulated MIR941 and MIR1247 target gastric cancer cell growth and migration. Epigenetics. 2014;9:1018-1030. [PMID: 24785261 DOI: 10.4161/epi.29007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
226 Mosakhani N, Sarhadi VK, Borze I, Karjalainen-Lindsberg ML, Sundström J, Ristamäki R, Osterlund P, Knuutila S. MicroRNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosomes Cancer. 2012;51:1-9. [PMID: 21922590 DOI: 10.1002/gcc.20925] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 7.0] [Reference Citation Analysis]
227 Guo H, Qi RQ, Lv YN, Wang HX, Hong YX, Zheng S, Li JH, Gao XH, Chen HD. miR-31 is distinctively overexpressed in primary male extramammary Paget's disease. Oncotarget 2016;7:24559-63. [PMID: 27016415 DOI: 10.18632/oncotarget.8230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
228 Wu X, Shen J, Xiao Z, Li J, Zhao Y, Zhao Q, Cho CH, Li M. An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets. Biochem Pharmacol 2019;163:425-39. [PMID: 30857828 DOI: 10.1016/j.bcp.2019.03.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
229 Yang Z, Lv NH. Role of PTEN in gastric carcinogenesis. Shijie Huaren Xiaohua Zazhi 2011; 19(6): 608-613 [DOI: 10.11569/wcjd.v19.i6.608] [Reference Citation Analysis]
230 Hébert SS, Nelson PT. Studying microRNAs in the brain: technical lessons learned from the first ten years. Exp Neurol 2012;235:397-401. [PMID: 22178329 DOI: 10.1016/j.expneurol.2011.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
231 Chiang Y, Zhou X, Wang Z, Song Y, Liu Z, Zhao F, Zhu J, Xu H. Expression levels of microRNA-192 and -215 in gastric carcinoma. Pathol Oncol Res. 2012;18:585-591. [PMID: 22205577 DOI: 10.1007/s12253-011-9480-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
232 Li F, Liu J, Li S. MicorRNA 106b~25 cluster and gastric cancer. Surg Oncol. 2013;22:e7-10. [PMID: 23510949 DOI: 10.1016/j.suronc.2013.01.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
233 Moreira FC, Assumpção M, Hamoy IG, Darnet S, Burbano R, Khayat A, Gonçalves AN, Alencar DO, Cruz A, Magalhães L, Araújo W Jr, Silva A, Santos S, Demachki S, Assumpção P, Ribeiro-dos-Santos A. MiRNA expression profile for the human gastric antrum region using ultra-deep sequencing. PLoS One 2014;9:e92300. [PMID: 24647245 DOI: 10.1371/journal.pone.0092300] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
234 Gallagher MF, Flavin RJ, Elbaruni SA, McInerney JK, Smyth PC, Salley YM, Vencken SF, O'Toole SA, Laios A, Lee MY, Denning K, Li J, Aherne ST, Lao KQ, Martin CM, Sheils OM, O'Leary JJ. Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients. J Ovarian Res 2009;2:19. [PMID: 20015364 DOI: 10.1186/1757-2215-2-19] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
235 Hatziapostolou M, Polytarchou C, Iliopoulos D. miRNAs link metabolic reprogramming to oncogenesis. Trends Endocrinol Metab 2013;24:361-73. [PMID: 23602813 DOI: 10.1016/j.tem.2013.03.002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
236 Wang WX, Kyprianou N, Wang X, Nelson PT. Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group. Cancer Res 2010;70:9137-42. [PMID: 20884628 DOI: 10.1158/0008-5472.CAN-10-1684] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
237 Imanaka Y, Tsuchiya S, Sato F, Shimada Y, Shimizu K, Tsujimoto G. MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. J Hum Genet 2011;56:270-6. [DOI: 10.1038/jhg.2011.1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
238 Yang S, Huang C, Li X, Yu M, He Y, Li J. miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology 2013;306:162-8. [DOI: 10.1016/j.tox.2013.02.014] [Cited by in Crossref: 129] [Cited by in F6Publishing: 133] [Article Influence: 14.3] [Reference Citation Analysis]
239 Dehghanzadeh R, Jadidi-Niaragh F, Gharibi T, Yousefi M. MicroRNA-induced drug resistance in gastric cancer. Biomed Pharmacother. 2015;74:191-199. [PMID: 26349984 DOI: 10.1016/j.biopha.2015.08.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
240 Wang Z, Yang B. Detection, Profiling, and Quantification of miRNA Expression. MicroRNA Expression Detection Methods. Berlin: Springer Berlin Heidelberg; 2010. pp. 3-64. [DOI: 10.1007/978-3-642-04928-6_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
241 Kang W, Tong JH, Lung RW, Dong Y, Zhao J, Liang Q, Zhang L, Pan Y, Yang W, Pang JC, Cheng AS, Yu J, To KF. Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma. Mol Cancer. 2015;14:52. [PMID: 25743273 DOI: 10.1186/s12943-015-0323-3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 11.3] [Reference Citation Analysis]
242 Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 2011; 17(35): 3976-3985 [PMID: 22046085 DOI: 10.3748/wjg.v17.i35.3976] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
243 Lianos GD, Glantzounis GK, Bali CD, Katsios C, Roukos DH. Identification of novel genes by whole-exome sequencing can improve gastric cancer precision oncology. Future Oncology 2017;13:883-92. [DOI: 10.2217/fon-2016-0430] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
244 Cherradi N. microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges. Front Endocrinol (Lausanne) 2015;6:195. [PMID: 26834703 DOI: 10.3389/fendo.2015.00195] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
245 Mohammadian F, Pilehvar-soltanahmadi Y, Zarghami F, Akbarzadeh A, Zarghami N. Upregulation of miR-9 and Let-7a by nanoencapsulated chrysin in gastric cancer cells. Artificial Cells, Nanomedicine, and Biotechnology 2017;45:1201-6. [DOI: 10.1080/21691401.2016.1216854] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
246 Kolenda T, Guglas K, Kopczyńska M, Sobocińska J, Teresiak A, Bliźniak R, Lamperska K. Good or not good: Role of miR-18a in cancer biology. Rep Pract Oncol Radiother 2020;25:808-19. [PMID: 32884453 DOI: 10.1016/j.rpor.2020.07.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
247 Wang JL, Hu Y, Kong X, Wang ZH, Chen HY, Xu J, Fang JY. Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study. PLoS One. 2013;8:e73683. [PMID: 24040025 DOI: 10.1371/journal.pone.0073683] [Cited by in Crossref: 51] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
248 Yang D, Zhao D, Chen X. MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression. Cancer Biomark 2017;19:425-36. [PMID: 28582847 DOI: 10.3233/CBM-160421] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
249 Ma M, Zhao J, Wu Q, Xiao K, Li S, Zhu H, Liu C, Xie H, Zuo C. MiRNA-545 negatively regulates the oncogenic activity of EMS1 in gastric cancer. Cancer Med 2018;7:2452-62. [PMID: 29733519 DOI: 10.1002/cam4.1520] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
250 Paul S, Maji P. μHEM for identification of differentially expressed miRNAs using hypercuboid equivalence partition matrix. BMC Bioinformatics 2013;14:266. [PMID: 24006840 DOI: 10.1186/1471-2105-14-266] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
251 Tang P, Xiong Q, Ge W, Zhang L. The role of microRNAs in osteoclasts and osteoporosis. RNA Biol 2014;11:1355-63. [PMID: 25692234 DOI: 10.1080/15476286.2014.996462] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 10.4] [Reference Citation Analysis]
252 Deftereos G, Corrie SR, Feng Q, Morihara J, Stern J, Hawes SE, Kiviat NB. Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One. 2011;6:e28423. [PMID: 22194833 DOI: 10.1371/journal.pone.0028423] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 6.5] [Reference Citation Analysis]
253 Nelson PT, Kiriakidou M, Mourelatos Z, Tan GS, Jennings MH, Xie K, Wang WX. High-throughput experimental studies to identify miRNA targets directly, with special focus on the mammalian brain. Brain Res 2010;1338:122-30. [PMID: 20380813 DOI: 10.1016/j.brainres.2010.03.108] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
254 Khan SY, Tariq MA, Perrott JP, Brumbaugh CD, Kim HJ, Shabbir MI, Ramesh GT, Pourmand N. Distinctive microRNA expression signatures in proton-irradiated mice. Mol Cell Biochem 2013;382:225-35. [PMID: 23817773 DOI: 10.1007/s11010-013-1738-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
255 Wang N, Wei H, Yin D, Lu Y, Zhang Y, Zhang Q, Ma X, Zhang S. MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a. Tumor Biol 2016;37:4711-20. [DOI: 10.1007/s13277-015-4292-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
256 Yang MH, Yu J, Chen N, Wang XY, Liu XY, Wang S, Ding YQ. Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2. PLoS One. 2013;8:e85353. [PMID: 24386467 DOI: 10.1371/journal.pone.0085353] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 6.7] [Reference Citation Analysis]
257 Ujifuku K, Mitsutake N, Takakura S, Matsuse M, Saenko V, Suzuki K, Hayashi K, Matsuo T, Kamada K, Nagata I, Yamashita S. miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett 2010;296:241-8. [PMID: 20444541 DOI: 10.1016/j.canlet.2010.04.013] [Cited by in Crossref: 146] [Cited by in F6Publishing: 132] [Article Influence: 12.2] [Reference Citation Analysis]
258 Dong X, Zhao Z, Hu Y, Lu Y, Liu P, Zhang L. LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis. Gastric Cancer 2020;23:260-72. [DOI: 10.1007/s10120-019-01011-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
259 Cui L, Zhang X, Ye G, Zheng T, Song H, Deng H, Xiao B, Xia T, Yu X, Le Y. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer. Cancer. 2013;119:1618-1626. [PMID: 23335180 DOI: 10.1002/cncr.27903] [Cited by in Crossref: 92] [Cited by in F6Publishing: 92] [Article Influence: 10.2] [Reference Citation Analysis]
260 Latchana N, Regan K, Howard JH, Aldrink JH, Ranalli MA, Peters SB, Zhang X, Gru A, Payne PRO, Suarez-Kelly LP, Carson WE 3rd. Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors. J Surg Res 2016;205:350-8. [PMID: 27664883 DOI: 10.1016/j.jss.2016.06.085] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
261 Zhang H, Shen Y, Li Z, Ruan Y, Li T, Xiao B, Sun W. The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers. J Clin Lab Anal 2020;34:e23049. [PMID: 31556152 DOI: 10.1002/jcla.23049] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
262 Bassampour SA, Abdi R, Bahador R, Shakeri M, Torkaman A, Yahaghi E, Taheriazam A. RETRACTED ARTICLE: Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival. Tumour Biol 2015. [PMID: 26277789 DOI: 10.1007/s13277-015-3918-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
263 Rittig AH, Johansen C, Celis P, Odum N, Litman T, Woetmann A, Lindahl LM, Iversen L. Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation. Exp Dermatol 2021;30:1141-9. [PMID: 32492224 DOI: 10.1111/exd.14124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
264 Fan B, Shen C, Wu M, Zhao J, Guo Q, Luo Y. miR-17-92 cluster is connected with disease progression and oxaliplatin/capecitabine chemotherapy efficacy in advanced gastric cancer patients: A preliminary study. Medicine (Baltimore) 2018;97:e12007. [PMID: 30170406 DOI: 10.1097/MD.0000000000012007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
265 Wang J, Wang Q, Liu H, Hu B, Zhou W, Cheng Y. MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer. Cancer Lett. 2010;297:137-143. [PMID: 20797817 DOI: 10.1016/j.canlet.2010.07.018] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
266 Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P, Kren L, Michalek J, Vyzula R. Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J Exp Clin Cancer Res. 2010;29:90. [PMID: 20609231 DOI: 10.1186/1756-9966-29-90] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 6.8] [Reference Citation Analysis]
267 Tsujiura M, Komatsu S, Ichikawa D, Shiozaki A, Konishi H, Takeshita H, Moriumura R, Nagata H, Kawaguchi T, Hirajima S. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer. Gastric Cancer. 2015;18:271-279. [PMID: 24626859 DOI: 10.1007/s10120-014-0363-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 6.6] [Reference Citation Analysis]
268 Zhang Y, Guo J, Li D, Xiao B, Miao Y, Jiang Z, Zhuo H. Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med Oncol. 2010;27:685-689. [PMID: 19598010 DOI: 10.1007/s12032-009-9269-x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 75] [Article Influence: 5.2] [Reference Citation Analysis]
269 Li F, Huang J, Liu J, Xu W, Yuan Z. Multivariate analysis of clinicopathological and prognostic significance of miRNA 106b~25 cluster in gastric cancer. Cancer Cell Int 2019;19:200. [PMID: 31384175 DOI: 10.1186/s12935-019-0918-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
270 Hichino A, Okamoto M, Taga S, Akizuki R, Endo S, Matsunaga T, Ikari A. Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells. J Biol Chem 2017;292:2411-21. [PMID: 28057758 DOI: 10.1074/jbc.M116.762807] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
271 Schaalan M, Mohamed W, Fathy S. MiRNA-200c, MiRNA-139 and ln RNA H19; new predictors of treatment response in H-pylori- induced gastric ulcer or progression to gastric cancer. Microb Pathog 2020;149:104442. [PMID: 32795593 DOI: 10.1016/j.micpath.2020.104442] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
272 Arif KMT, Elliott EK, Haupt LM, Griffiths LR. Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets. Cancers (Basel) 2020;12:E2922. [PMID: 33050637 DOI: 10.3390/cancers12102922] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
273 Yang TS, Yang XH, Chen X, Wang XD, Hua J, Zhou DL, Zhou B, Song ZS. MicroRNA-106b in cancer-associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN. FEBS Lett. 2014;588:2162-2169. [PMID: 24842611 DOI: 10.1016/j.febslet.2014.04.050] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 8.3] [Reference Citation Analysis]
274 Zhang HD, Sun DW, Mao L, Zhang J, Jiang LH, Li J, Wu Y, Ji H, Chen W, Wang J, Ma R, Cao HX, Wu JZ, Tang JH. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel. Biochem Biophys Res Commun 2015;465:702-13. [PMID: 26299922 DOI: 10.1016/j.bbrc.2015.08.053] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 8.6] [Reference Citation Analysis]
275 Takahashi K, Yan I, Wen HJ, Patel T. microRNAs in liver disease: from diagnostics to therapeutics. Clin Biochem. 2013;46:946-952. [PMID: 23396165 DOI: 10.1016/j.clinbiochem] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
276 Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, Choi IJ, Munroe DJ, Green JE. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics. 2011;4:79. [PMID: 22112324 DOI: 10.1186/1755-8794-4-79] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 7.7] [Reference Citation Analysis]
277 Ankasha SJ, Shafiee MN, Wahab NA, Ali RAR, Mokhtar NM. Post-transcriptional regulation of microRNAs in cancer: From prediction to validation. Oncol Rev 2018;12:344. [PMID: 29989022 DOI: 10.4081/oncol.2018.344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
278 Ma T, Wang RP, Zou X. Dioscin inhibits gastric tumor growth through regulating the expression level of lncRNA HOTAIR. BMC Complement Altern Med 2016;16:383. [PMID: 27751178 DOI: 10.1186/s12906-016-1360-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
279 Takahashi K, Yan I, Wen HJ, Patel T. microRNAs in liver disease: from diagnostics to therapeutics. Clin Biochem 2013;46:946-52. [PMID: 23396165 DOI: 10.1016/j.clinbiochem.2013.01.025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
280 Yu D, Shin H, Lee YS, Lee YC. miR-106b modulates cancer stem cell characteristics through TGF-β/Smad signaling in CD44-positive gastric cancer cells. Lab Invest 2014;94:1370-81. [DOI: 10.1038/labinvest.2014.125] [Cited by in Crossref: 56] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]
281 Soreq L, Salomonis N, Bronstein M, Greenberg DS, Israel Z, Bergman H, Soreq H. Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes. Front Mol Neurosci 2013;6:10. [PMID: 23717260 DOI: 10.3389/fnmol.2013.00010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 7.9] [Reference Citation Analysis]
282 Cagnin S, Caraballo M, Guiducci C, Martini P, Ross M, Santaana M, Danley D, West T, Lanfranchi G. Overview of electrochemical DNA biosensors: new approaches to detect the expression of life. Sensors (Basel) 2009;9:3122-48. [PMID: 22574066 DOI: 10.3390/s90403122] [Cited by in Crossref: 91] [Cited by in F6Publishing: 70] [Article Influence: 7.0] [Reference Citation Analysis]
283 Deng H, Guo Y, Song H, Xiao B, Sun W, Liu Z, Yu X, Xia T, Cui L, Guo J. MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. Gene 2013;518:351-9. [PMID: 23333942 DOI: 10.1016/j.gene.2012.12.103] [Cited by in Crossref: 106] [Cited by in F6Publishing: 101] [Article Influence: 11.8] [Reference Citation Analysis]
284 Li K, Han F, Wu Y, Wang X. miR-340 Promotes Retinoblastoma Cell Proliferation, Migration and Invasion Through Targeting WIF1. Onco Targets Ther 2021;14:3635-48. [PMID: 34113129 DOI: 10.2147/OTT.S302800] [Reference Citation Analysis]
285 Gruszka R, Zakrzewski K, Liberski PP, Zakrzewska M. mRNA and miRNA Expression Analyses of the MYC/E2F/miR-17-92 Network in the Most Common Pediatric Brain Tumors. Int J Mol Sci 2021;22:E543. [PMID: 33430425 DOI: 10.3390/ijms22020543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
286 Liu D, Zhang H, Ge S, Lin D, Han J, Ying G, Ba Y. Identification of HGF as a novel target of miR-15a/16/195 in gastric cancer. Invest New Drugs 2020;38:922-33. [PMID: 31414268 DOI: 10.1007/s10637-019-00834-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
287 Li L, Guo Z, Wang J, Mao Y, Gao Q. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci. 2012;57:2910-2916. [PMID: 22865399 DOI: 10.1007/s10620-012-2317-y] [Cited by in Crossref: 64] [Cited by in F6Publishing: 70] [Article Influence: 6.4] [Reference Citation Analysis]
288 You W, Zhang X, Ji M, Yu Y, Chen C, Xiong Y, Liu Y, Sun Y, Tan C, Zhang H, Li J, Chen W, Li R. MiR-152-5p as a microRNA passenger strand special functions in human gastric cancer cells. Int J Biol Sci 2018;14:644-53. [PMID: 29904279 DOI: 10.7150/ijbs.25272] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
289 Zhang H, Jiang L, Sun D, Li J, Tang J. MiR-139-5p: promising biomarker for cancer. Tumor Biol 2015;36:1355-65. [DOI: 10.1007/s13277-015-3199-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 7.1] [Reference Citation Analysis]
290 Strickertsson JA, Rasmussen LJ, Friis-Hansen L. Enterococcus faecalis Infection and Reactive Oxygen Species Down-Regulates the miR-17-92 Cluster in Gastric Adenocarcinoma Cell Culture. Genes (Basel) 2014;5:726-38. [PMID: 25170597 DOI: 10.3390/genes5030726] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
291 Libânio D, Dinis-Ribeiro M, Pimentel-Nunes P. Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions. World J Clin Oncol 2015; 6(5): 111-132 [PMID: 26468448 DOI: 10.5306/wjco.v6.i5.111] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
292 Xu G, Ye D, Zhao Q, He R, Ma W, Li Y, Tang S, Zhou Z, Li X, Zhang Z. circNFIC suppresses breast cancer progression by sponging miR-658. J Cancer 2020;11:4222-9. [PMID: 32368305 DOI: 10.7150/jca.38830] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
293 Treece AL, Duncan DL, Tang W, Elmore S, Morgan DR, Dominguez RL, Speck O, Meyers MO, Gulley ML. Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns. Lab Invest. 2016;96:661-671. [PMID: 26950485 DOI: 10.1038/labinvest.2016.33] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
294 Xu S, Linher-Melville K, Yang BB, Wu D, Li J. Micro-RNA378 (miR-378) regulates ovarian estradiol production by targeting aromatase. Endocrinology 2011;152:3941-51. [PMID: 21846797 DOI: 10.1210/en.2011-1147] [Cited by in Crossref: 136] [Cited by in F6Publishing: 132] [Article Influence: 12.4] [Reference Citation Analysis]
295 Nam RK, Amemiya Y, Benatar T, Wallis CJ, Stojcic-Bendavid J, Bacopulos S, Sherman C, Sugar L, Naeim M, Yang W, Zhang A, Klotz LH, Narod SA, Seth A. Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort Study. J Cancer 2015;6:1160-71. [PMID: 26516365 DOI: 10.7150/jca.13397] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
296 Cheng J, Zhuo H, Wang L, Zheng W, Chen X, Hou J, Zhao J, Cai J. Identification of the Combinatorial Effect of miRNA Family Regulatory Network in Different Growth Patterns of GC. Mol Ther Oncolytics 2020;17:531-46. [PMID: 32637572 DOI: 10.1016/j.omto.2020.03.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
297 Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu CW, Wang K, Zheng S, Ng SS, Chan FK, Sung JJ, Yu J. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Mol Cancer 2014;13:124. [PMID: 24885920 DOI: 10.1186/1476-4598-13-124] [Cited by in Crossref: 84] [Cited by in F6Publishing: 89] [Article Influence: 10.5] [Reference Citation Analysis]
298 Jo P, Azizian A, Salendo J, Kramer F, Bernhardt M, Wolff HA, Gruber J, Grade M, Beißbarth T, Ghadimi BM, Gaedcke J. Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy. Int J Mol Sci 2017;18:E1140. [PMID: 28554991 DOI: 10.3390/ijms18061140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
299 Hong S, Yu S, Li J, Yin Y, Liu Y, Zhang Q, Guan H, Li Y, Xiao H. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Thyroid 2016;26:1733-43. [DOI: 10.1089/thy.2015.0578] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
300 Choi B, Yu J, Han TS, Kim YK, Hur K, Kang BC, Kim WH, Kim DY, Lee HJ, Kim VN, Yang HK. Gastric Carcinogenesis in the miR-222/221 Transgenic Mouse Model. Cancer Res Treat 2017;49:150-60. [PMID: 27338035 DOI: 10.4143/crt.2015.462] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
301 Song B, Ju J. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis. Expert Rev Mol Med 2010;12:e33. [PMID: 20942990 DOI: 10.1017/S1462399410001663] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
302 Shen Z, Zhan G, Ye D, Ren Y, Cheng L, Wu Z, Guo J. MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin. Med Oncol 2012;29:2473-80. [DOI: 10.1007/s12032-011-0156-x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 5.8] [Reference Citation Analysis]
303 Peng WZ, Ma R, Wang F, Yu J, Liu ZB. Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer. Int J Mol Sci. 2014;15:4031-4048. [PMID: 24603541 DOI: 10.3390/ijms15034031] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
304 Zhang Y, Lin ZH, Jin TF, Jin RS. MicroRNA expression profile in colorectal cancer. Shijie Huaren Xiaohua Zazhi 2014; 22(30): 4578-4587 [DOI: 10.11569/wcjd.v22.i30.4578] [Reference Citation Analysis]
305 Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, Ma Y, Xiao H. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett. 2012;316:196-203. [PMID: 22169097 DOI: 10.1016/j.canlet.2011.10.034] [Cited by in Crossref: 174] [Cited by in F6Publishing: 174] [Article Influence: 15.8] [Reference Citation Analysis]
306 Li T, Shao Y, Fu L, Xie Y, Zhu L, Sun W, Yu R, Xiao B, Guo J. Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection. J Mol Med (Berl). 2018;96:85-96. [PMID: 29098316 DOI: 10.1007/s00109-017-1600-y] [Cited by in Crossref: 114] [Cited by in F6Publishing: 121] [Article Influence: 22.8] [Reference Citation Analysis]
307 Soond SM, Kozhevnikova MV, Townsend PA, Zamyatnin AA Jr. Integrative p53, micro-RNA and Cathepsin Protease Co-Regulatory Expression Networks in Cancer. Cancers (Basel) 2020;12:E3454. [PMID: 33233599 DOI: 10.3390/cancers12113454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
308 Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene. 2010;29:5761-5771. [PMID: 20802530 DOI: 10.1038/onc.2010.352] [Cited by in Crossref: 196] [Cited by in F6Publishing: 197] [Article Influence: 16.3] [Reference Citation Analysis]
309 Tchernitsa O, Kasajima A, Schäfer R, Kuban RJ, Ungethüm U, Györffy B, Neumann U, Simon E, Weichert W, Ebert MP. Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J Pathol. 2010;222:310-319. [PMID: 20726036 DOI: 10.1002/path.2759] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 7.9] [Reference Citation Analysis]
310 Patel TN, Roy S, Ravi R. Gastric cancer and related epigenetic alterations. Ecancermedicalscience. 2017;11:714. [PMID: 28144288 DOI: 10.3332/ecancer.2017.714] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
311 Paranjape T, Slack FJ, Weidhaas JB. MicroRNAs: tools for cancer diagnostics. Gut 2009;58:1546-54. [PMID: 19834118 DOI: 10.1136/gut.2009.179531] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 6.7] [Reference Citation Analysis]
312 Jiang Z, Guo J, Xiao B, Miao Y, Huang R, Li D, Zhang Y. Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol. 2010;45:17-23. [PMID: 19802518 DOI: 10.1007/s00535-009-0135-6] [Cited by in Crossref: 91] [Cited by in F6Publishing: 100] [Article Influence: 7.0] [Reference Citation Analysis]
313 Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130. [PMID: 16514137 DOI: 10.1007/s11010-010-0463-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
314 Li W, Jin X, Deng X, Zhang G, Zhang B, Ma L. The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E. Biochem Biophys Res Commun. 2014;449:235-240. [PMID: 24845562 DOI: 10.1016/j.bbrc.2014.05.011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
315 Rezayi M, Farjami Z, Hosseini ZS, Ebrahimi N, Abouzari-lotf E. MicroRNA-based Biosensors for Early Detection of Cancers. CPD 2019;24:4675-80. [DOI: 10.2174/1381612825666190111144525] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
316 Schmittgen TD. miR-31: a master regulator of metastasis? Future Oncology 2010;6:17-20. [DOI: 10.2217/fon.09.150] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
317 Liu L, Shao X, Gao W, Zhang Z, Liu P, Wang R, Huang P, Yin Y, Shu Y. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor. FEBS J. 2012;279:3800-3812. [PMID: 22883469 DOI: 10.1111/j.1742-4658.2012.08741.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
318 Ferdin J, Kunej T, Calin GA. Non-coding RNAs: identification of cancer-associated microRNAs by gene profiling. Technol Cancer Res Treat 2010;9:123-38. [PMID: 20218735 DOI: 10.1177/153303461000900202] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
319 Parasramka MA, Ali S, Banerjee S, Deryavoush T, Sarkar FH, Gupta S. Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures. Mol Nutr Food Res 2013;57:235-48. [PMID: 23293055 DOI: 10.1002/mnfr.201200297] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
320 Li Y, Chen M, Liu J, Li L, Yang X, Zhao J, Wu M, Ye M. Upregulation of MicroRNA 18b Contributes to the Development of Colorectal Cancer by Inhibiting CDKN2B. Mol Cell Biol 2017;37:e00391-17. [PMID: 28784723 DOI: 10.1128/MCB.00391-17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
321 Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer. 2013;132:116-127. [PMID: 22674182 DOI: 10.1002/ijc.27657] [Cited by in Crossref: 130] [Cited by in F6Publishing: 123] [Article Influence: 13.0] [Reference Citation Analysis]
322 Zhong X, Yu J, Zhang W, Wang Z, Dong Q, Tai S, Cui Y, Li H. MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene 2012;493:44-51. [DOI: 10.1016/j.gene.2011.11.028] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
323 Jiang C, Chen X, Alattar M, Wei J, Liu H. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer. Cancer Gene Ther 2015;22:291-301. [DOI: 10.1038/cgt.2015.19] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 8.9] [Reference Citation Analysis]
324 Cooke CL, Torres J, Solnick JV. Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes. 2013;4:532-540. [PMID: 23851317 DOI: 10.4161/gmic.25720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
325 Wang Z, Ma B, Ji X, Deng Y, Zhang T, Zhang X, Gao H, Sun H, Wu H, Chen X. MicroRNA-378-5p suppresses cell proliferation and induces apoptosis in colorectal cancer cells by targeting BRAF. Cancer Cell Int. 2015;15:40. [PMID: 25977643 DOI: 10.1186/s12935-015-0192-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
326 Samuel P, Pink RC, Caley DP, Currie JM, Brooks SA, Carter DR. Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells. Tumour Biol 2016;37:2565-73. [PMID: 26386726 DOI: 10.1007/s13277-015-4081-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
327 Tazawa H, Kagawa S, Fujiwara T. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors. Expert Opin Biol Ther 2011;11:145-55. [PMID: 21219233 DOI: 10.1517/14712598.2011.542749] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
328 Wang Z, Liu M, Zhu H, Zhang W, He S, Hu C, Quan L, Bai J, Xu N. miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS. Mol Carcinog. 2013;52:634-646. [PMID: 22431000 DOI: 10.1002/mc.21899] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
329 Wang F, Liu J, Zou Y, Jiao Y, Huang Y, Fan L, Li X, Yu H, He C, Wei W, Wang H, Sun G. MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2. Oncotarget 2017;8:28711-24. [PMID: 28404925 DOI: 10.18632/oncotarget.15646] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
330 Zhou P, Jiang W, Wu L, Chang R, Wu K, Wang Z. miR-301a is a candidate oncogene that targets the homeobox gene Gax in human hepatocellular carcinoma. Dig Dis Sci. 2012;57:1171-1180. [PMID: 22373864 DOI: 10.1007/s10620-012-2099-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 4.7] [Reference Citation Analysis]
331 Sabbah NA, Abdalla WM, Mawla WA, AbdAlMonem N, Gharib AF, Abdul-Saboor A, Abdelazem AS, Raafat N. piRNA-823 Is a Unique Potential Diagnostic Non-Invasive Biomarker in Colorectal Cancer Patients. Genes (Basel) 2021;12:598. [PMID: 33921704 DOI: 10.3390/genes12040598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]